➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

IRON DEXTRAN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for iron dextran and what is the scope of patent protection?

Iron dextran is the generic ingredient in four branded drugs marketed by Am Regent, Allergan, Sanofi Aventis Us, and New River, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are eighty-two drug master file entries for iron dextran. Five suppliers are listed for this compound.

Summary for IRON DEXTRAN
Recent Clinical Trials for IRON DEXTRAN

Identify potential brand extensions & 505(b)(2) entrants

Hospital for Special Surgery, New YorkPhase 1
Orthopedic Research and Education FoundationPhase 1
West China HospitalN/A

See all IRON DEXTRAN clinical trials

Pharmacology for IRON DEXTRAN

US Patents and Regulatory Information for IRON DEXTRAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan INFED iron dextran INJECTABLE;INJECTION 017441-001 Approved Prior to Jan 1, 1982 BP RX Yes Yes   Start Trial   Start Trial   Start Trial
New River PROFERDEX iron dextran INJECTABLE;INJECTION 017807-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us IRON DEXTRAN iron dextran INJECTABLE;INJECTION 010787-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.